
Aaron E. Katz, MD, FACS, discusses redefining risk stratification for men with prostate cancer.

Your AI-Trained Oncology Knowledge Connection!


Aaron E. Katz, MD, FACS, discusses redefining risk stratification for men with prostate cancer.

Aaron E. Katz, MD, FACS, discusses the Oncotype DX Genomic Prostate Score assay in patients with prostate cancer.

Aaron E. Katz, MD, FACS, discusses re-classifying low-risk prostate scores with the 17-gene Oncotype DX Genomic Prostate Score.

Aaron E. Katz, MD, FACS, discusses strategies for determining low-risk prostate cancer.

Published: June 2nd 2020 | Updated:

Published: June 3rd 2020 | Updated: